Intercept to Announce Second Quarter 2023 Financial Results on August 2, 2023
26 Julho 2023 - 9:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a
biopharmaceutical company focused on the development and
commercialization of novel therapeutics to treat rare and serious
liver diseases, will announce its second quarter 2023 financial
results on Wednesday, August 2, 2023. The announcement will be
followed by a conference call and audio webcast at 8:30 a.m.
ET.
Participants can access the conference call live
via webcast which will be available on the investor page of the
company’s website at http://ir.interceptpharma.com. Participants
who wish to ask a question may register here to receive dial-in
numbers and a unique pin to join the call. While not required, it
is recommended you join 10 minutes prior to the event's start. A
replay of the call will be available on Intercept’s website
following the completion of the call.
About Intercept Intercept
is a biopharmaceutical company focused on the development and
commercialization of novel therapeutics to treat rare and serious
liver diseases, including primary biliary cholangitis (PBC) and
severe alcohol-associated hepatitis (sAH). For more information,
please visit www.interceptpharma.com or connect with the Company on
Twitter and LinkedIn.
Contact For more
information about Intercept, please contact:
Investor
inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024